Stockscreener 앱 받기
1.41
0.70%
0.02
전일 마감가:
$1.43
열려 있는:
$1.44
하루 거래량:
61,372
Relative Volume:
0.22
시가총액:
$183.24M
수익:
-
순이익/손실:
$-13.73M
주가수익비율:
-10.85
EPS:
-0.13
순현금흐름:
$-3.92M
1주 성능:
-1.37%
1개월 성능:
+13.39%
6개월 성능:
-13.25%
1년 성능:
+5.88%
1일 변동 폭
$1.39
$1.4697
1주일 범위
$1.36
$1.57
52주 변동 폭
$0.7301
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Compare TLSA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.44 | 181.96M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.04 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
723.34 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.23 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2018-12-17 | 개시 | Laidlaw | Buy |
Tiziana Life Sciences Ltd 주식(TLSA)의 최신 뉴스
Day Trade: Can Tiziana Life Sciences Ltd maintain its current growth rate2025 Volume Leaders & Momentum Based Trading Ideas - baoquankhu1.vn
Market movers: Circle Internet Group, Tiziana Life Sciences, Cava, Lowe’s… - Proactive Investors
Tiziana reports biomarker gains for nasal MS therapy in progressive disease - Yahoo
Tiziana Life Sciences PLC (TLSA) announces new biomarker data - Bitget
Tiziana Life Sciences Posts Positive Biomarker Data for Intranasal Foralumab in Progressive MS - TipRanks
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA - The Manila Times
New foralumab biomarker data in na-SPMS from Tiziana (Nasdaq: TLSA) - Stock Titan
New nasal treatment calms brain immune activity in progressive MS patients - Stock Titan
What’s next for Tiziana Life Sciences Ltd stockIndex Update & Safe Capital Growth Stock Tips - mfd.ru
Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 0.7%Here's What Happened - MarketBeat
Does Tiziana Life Sciences Ltd outperform in volatile markets2025 Growth vs Value & Short-Term Trading Alerts - mfd.ru
What is Tiziana Life Sciences Ltd s 5 year growth outlookM&A Rumor & Smart Allocation Stock Reports - mfd.ru
TLSA PE Ratio & Valuation, Is TLSA Overvalued - Intellectia AI
TLSA Should I Buy - Intellectia AI
Is Tiziana Life Sciences Ltd stock affected by interest rate hikesPortfolio Value Report & Risk Adjusted Buy and Sell Alerts - mfd.ru
How Tiziana Life Sciences Ltd stock reacts to Fed rate cutsWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - mfd.ru
Is Tiziana Life Sciences Ltd in a consolidation phaseEarnings Miss & Weekly High Potential Stock Alerts - mfd.ru
Can Tiziana Life Sciences Ltd sustain earnings growth2025 Trade Ideas & Safe Capital Growth Stock Tips - mfd.ru
Investment Review: Is Tiziana Life Sciences Ltd stock overvalued or fairly priced2025 Macro Impact & Short-Term High Return Ideas - baoquankhu1.vn
Profit Review: Is Tiziana Life Sciences Ltd a stock for growth or value investors2025 Volume Leaders & AI Optimized Trade Strategies - baoquankhu1.vn
What are the future prospects of MAIA Biotechnology IncSwing Trade & Daily Technical Forecast Reports - baoquankhu1.vn
Income Plays: What are the future prospects of Tiziana Life Sciences Ltd2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - baoquankhu1.vn
While insiders own 43% of Tiziana Life Sciences Ltd (NASDAQ:TLSA), individual investors are its largest shareholders with 53% ownership - Yahoo Finance
Earnings Update: Is Tiziana Life Sciences Ltd subject to activist investor interestTrade Exit Report & Precise Swing Trade Alerts - baoquankhu1.vn
Revenue Check: Is Tiziana Life Sciences Ltd subject to activist investor interestQuarterly Market Review & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Market Recap: Is KRYS stock a value trap2025 Risk Factors & Verified Momentum Stock Alerts - baoquankhu1.vn
Can Tiziana Life Sciences Ltd expand its profit marginsWeekly Trade Summary & Reliable Breakout Forecasts - baoquankhu1.vn
Performance Recap: Can Tiziana Life Sciences Ltd maintain its current growth rate - baoquankhu1.vn
Breakout Zone: Will Tiziana Life Sciences Ltd outperform its industry peersInsider Selling & Weekly Watchlist of Top Performers - baoquankhu1.vn
Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Up 3.1%Should You Buy? - MarketBeat
Pullback Watch: What are the future prospects of Tiziana Life Sciences LtdJuly 2025 EndofMonth & Verified Swing Trading Watchlist - baoquankhu1.vn
Market Recap: Does BHA have strong fundamentalsTrade Entry Summary & Short-Term High Return Ideas - baoquankhu1.vn
Tiziana's Intranasal Foralumab Study Results Published In Peer-Reviewed Journal - RTTNews
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab - The Manila Times
Tiziana Life Sciences (TLSA) Reports Positive Results in MS Stud - GuruFocus
Tiziana Life Sciences publishes positive study on intranasal MS therapy - Proactive financial news
Tiziana Life Sciences Publishes Positive Results of Intranasal Foralumab Study for Non-Active Secondary Progressive Multiple Sclerosis - Quiver Quantitative
Experimental nasal MS antibody steadies disability in small study - Stock Titan
Small cap wrap: American Resources, Tiziana Life Sciences, Digi Power X, Midnight Sun Mining... - Proactive financial news
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million - marketscreener.com
History Review: Can Tiziana Life Sciences Ltd sustain earnings growthEarnings Risk Summary & High Accuracy Trade Alerts - baoquankhu1.vn
Guidance Update: Is Tiziana Life Sciences Ltd likely to announce a buybackPortfolio Growth Summary & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Tiziana Life Sciences Raises $8.8 Million in Oversubscribed Direct Offering to Fund Phase 2 Trials - The Globe and Mail
Tiziana Life Sciences closes $8.8 million registered direct offering By Investing.com - Investing.com Nigeria
Orrick Advises Tiziana Life Sciences on Nasdaq Registered Direct Offering of Up to Approximately $17.6 Million - orrick.com
Tiziana Life Sciences Closes $8.8 Million Direct Offering of 7.04 Million Shares - Intellectia AI
Tiziana Life Sciences announces closing of oversubscribed $8.8M offering - Proactive financial news
Tiziana Life Sciences closes $8.8 million registered direct offering - Investing.com
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares - The Manila Times
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares - Benzinga
Tiziana leaders invest in $8.8M raise to finish Phase 2 na-SPMS, MSA trials - Stock Titan
Tiziana Life Sciences Ltd (TLSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.07%
0.71%
자본화:
|
볼륨(24시간):